Single-use TFF offers the greatest savings in clinical and contract manufacturing, where the scale is low and changeovers are frequent.
Mark Perreault
Advertisement
Mark Perreault is the director of membrane application development for TangenX technology at Novasep
Articles by Mark Perreault
Advertisement
Latest Updated Articles
An Economic Analysis of Single-Use Tangential Flow Filtration for Biopharmaceutical ApplicationsPublished: November 2nd 2010 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
